Bristol-Myers Squibb (BMY) Tops Q1 EPS by 10c

Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.93 billion versus the consensus estimate of $4.72 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2017 EPS of $2.85-$3.00, versus the consensus of $2.80.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• KB Home (KBH) Tops Q3 EPS by 16c